ABSTRACT
INTRODUCTION
Prenatal diagnosis of aortic stenosis is relatively rare, occurring in less than 10% of newborns requiring neonatal intervention 1 . Fetal aortic valvuloplasty (FV) is offered in the setting of significant aortic stenosis, with the intent to alter fetal left heart hemodynamics that might result in univentricular (UV) circulation after birth. However, the procedure is not without risk and experienced centers report a 10% procedure-related loss 2, 3 , with higher losses reported by multicenter registries with more varied experience 4 .
There are important challenges in conducting a randomized trial to assess risks and benefits of FV in this rare condition and natural history reports are limited by their sample size, quality of prenatal data and postnatal follow-up 5 -7 . Knowledge of the natural history of fetal aortic stenosis is important for health professionals providing fetal counseling.
The primary aim of this study was to report the spectrum of fetal left heart morphology and physiology, pregnancy outcome, survival and final circulatory pathways in a natural history cohort of aortic stenosis, established by the Fetal Working Group of the Association for European Paediatric Cardiology. A secondary aim was to test previously published selection criteria for emerging hypoplastic left heart syndrome (HLHS) and identify ideal candidates for FV in this population of fetuses by comparing predicted with observed outcomes 2, 6 .
METHODS
The multicenter multinational study of fetal aortic stenosis was established by the Fetal Working Group of the Association for European Paediatric Cardiology and involved 23 centers in 12 European countries from January 2005 to May 2012. In total, 214 fetuses with a spectrum of aortic valve diseases were enrolled, 67 of which underwent FV and are not reported here ( Figure 1 ). We present the natural history of 107 of these fetuses with aortic stenosis that did not undergo FV, with information obtained retrospectively. Alive (n = 9, median 7 (4.2-8.9) years) Demise (n = 4: 3 NND, 1 at 1.25 years)
All alive, median 7 (3.9-8.8) years
Alive (n = 14, median 6.3 (2.6-9.1) years) Demise (n = 9: 5 NND, 4 at median 1 (0.7-1.7) year)
BV-UV (n = 4) UV (n = 23) BV (n = 13) Cases suitable for inclusion in the study had usual atrial arrangements, concordant atrioventricular and ventriculoarterial connections with stenosed, but still patent, aortic valves. Associated findings of mitral valve hypoplasia, left ventricular fibroelastosis, coarctation and persistent left superior vena cava were accepted. The morphological and physiological data were collected prospectively and measured by the fetal cardiologists of the participating centers, and recorded on a standardized data collection form.
In order to facilitate data acquisition, the core investigators (A.K. and A.O.) offered to visit sites. In practice, most contributors sent completed data sheets to the core investigators, and 35% were visited by one coauthor (A.K.) who retrieved and documented the recorded measurements and added any missing measurements from available clips.
We documented right-and left-sided atrioventricular valve lateral diameters and ventricular sizes, Doppler velocities and waveform patterns through pulmonary veins, the ductus venosus, foramen ovale and both semilunar valves, and information about the aortic and ductal arches. The demographic data of the pregnancies and fetuses, and follow-up data were collated by A.K. and A.O., who also calculated Z-scores of the cardiac measurements based on gestational age 8 . The analysis of circulatory outcome was confined to cases that underwent (or intended) a postnatal surgical or catheter procedure during the neonatal period. None had multiple congenital abnormalities or abnormal karyotype and no maternal conditions or multiple pregnancies resulted in exclusion from the analysis. In ongoing pregnancies, Z-scores of aortic and mitral valves and left ventricular inlet length and width, and any change in physiological parameters recorded during the pregnancy at first and last echo were compared. We recorded mitral valve flow profile (biphasic, monophasic or absent), direction of flow in the aortic arch (forward or reversed including bidirectional) and across the atrial septum (right to left, left to right, restrictive or none) and the peak pressure gradient generated across the aortic and mitral valves. These variables were analyzed in relation to survival and circulatory outcome in the 80 liveborn neonates in which postnatal therapy was performed.
The postnatal surgical pathway was considered biventricular (BV) if the first procedure was balloon aortic valvuloplasty or surgical valvotomy, or if a Ross or Ross-Konno procedure was performed. The fetus followed a primary UV circulatory pathway when a primary Norwood or Hybrid procedure was performed and a BV-to-UV conversion if a BV procedure was followed by a Norwood or Hybrid procedure at any age. No children received a transplant and no UV circulation was later converted to BV using left ventricular rehabilitation strategies.
Previously published experience of the natural history of aortic stenosis from Boston in 2006 6 describes fetuses with aortic stenosis that are likely to develop HLHS during pregnancy. In order to derive the proportion of our natural history cohort expected to progress to HLHS using the Boston 2006 criteria, we took physiological data from the first fetal echocardiogram before 31 completed gestational weeks and combined this with the left ventricular inlet length (major axis) Z-scores ( Figure 2) .
We then included peak pressure gradients derived from mitral regurgitation jets and Doppler flow velocities across the aortic valve and applied the Boston 2009 threshold score to those selected previously as likely to develop HLHS according to Boston 2006 criteria. A threshold score of 4 or 5 defined the morphological dimensions and physiology necessary to permit a BV circulatory outcome following technically successful FV, thus defining the 'ideal FV candidate'. A score of 1 was awarded to fetuses for each Z-score meeting the following criteria: left ventricular inlet length and width > 0; mitral valve diameter > −2; aortic valve diameter > −3.5; and pressure gradient across either the mitral or aortic valve > 20 mmHg 2 . This enabled us to determine the proportion of fetuses with emerging HLHS that also fulfilled the criteria for an ideal FV candidate, yet circulation remained BV without fetal therapy.
The Ethics Committee at Imperial College London considered the study audit of practice and no specific ethical approval was required. Data from the postnatal pre-intervention echocardiogram in 71 cases of this natural history cohort have been used and reported previously in a blinded study of postnatal surgical decision-making 9 .
Statistical analysis
Summary statistics of the natural history fetal cohort are presented. Logistic regression was used to assess change in Z-score during pregnancy and its effect on postnatal circulation. The categorical physiological data were dichotomized to code for whether individual parameters changed during pregnancy, and Fisher's exact test was used to compare the effect on postnatal circulation. The Mann-Whitney U-test was used to analyze the continuous variables of gestation and left ventricular morphology by circulatory outcome. Odds ratios (OR) of overall survival (for any circulation) in those meeting the fetal criteria for emerging HLHS compared with those that did not were calculated. The effects of first and final circulation on survival were assessed using Kaplan-Meier survival curves. Statistical significance was determined at P < 0.05. Statistical analysis was performed with Stata version 13 (StataCorp, College Station, TX, USA).
RESULTS

Overview
Figure 1 summarizes the outcomes of the 147 fetuses that did not undergo FV from the whole cohort of 214 fetuses enrolled in the multicenter study. The mean ± SD gestational age at first fetal echocardiogram of these 147 fetuses with adequate data submitted to the study was 23.5 ± 5 weeks. Termination of pregnancy was performed in 40 (27.2%) pregnancies. Pregnancies ending in termination in the whole cohort of 214 fetuses were not affected more severely than ongoing pregnancies, but were examined at an earlier gestational age (Table S1 ).
Circulation and survival outcomes in ongoing pregnancies
In the 107 ongoing natural history pregnancies, there were eight spontaneous fetal deaths (7.5%), resulting in 99 liveborn neonates. No postnatal aortic valve interventions were performed in 14 of the 99 liveborns. Four never required intervention on the aortic valve during the study period and were excluded: three with mild aortic valve stenosis after birth and one with a primary lesion of coarctation with moderate aortic stenosis (30 mmHg peak gradient). A further five were lost to follow-up and five received comfort care. Therefore, there was intention-to-treat in 85 newborns with severe aortic stenosis. None had abnormal chromosomes and one was from a twin pregnancy. However, five died before surgery, including two that were born preterm (at 25 and 30 weeks, with the latter after attempts to open a closed atrial septum), and the circulation could not be determined. Ultimately, 80 neonates underwent postnatal procedures with 44 BV, 29 UV and seven BV-to-UV circulatory outcomes (Figure 1 ). Thirty-day survival was 81% (69/85) and survival at median 6 years was superior in cases with BV circulation (P = 0.041).
Hydrops
Twelve fetuses were hydropic; their age at presentation and pathophysiology are reported in Table S2 . Three suffered spontaneous fetal demise and one pregnancy with intact atrial septum was terminated. Of the eight liveborns, six died: one following attempted balloon aortic valvuloplasty, one after Rashkind and Norwood, two had comfort care and two died before any procedure could be performed. Only two cases survived (one was delivered at 33 weeks); both developed restrictive atrial septum, had antegrade fetal arch flow and only required balloon aortic valvuloplasty after birth. At the time of writing, aged 9.1 and 6.6 years, they were alive with BV circulation.
Changes in morphology and physiology during pregnancy in relation to outcome Table 1 compares fetal left heart Z-scores of 51 liveborns with data available before 30 gestational weeks and who survived for more than 3 months, according to their postnatal circulation. Children with BV circulation had better initial fetal Z-scores than did those with UV circulation, but the only significant variable was mitral valve diameter (P = 0.004).
In addition, Tables S3 and S4 show the Z-scores of variables at the first scan with sufficient data for all 80 children receiving treatment, grouped according to circulatory outcome (Table S3 ) and according to the time of demise in those dying before 3 months old (Table S4) . Logistic regression analysis of the 85 liveborns, treated or with intention-to-treat, demonstrated a four-fold increased risk of dying in cases classified as having evolving HLHS 6 (OR, 3.98 (95% CI, 1.56-10.14); P = 0.0028). Figure 3 shows the gestational changes in left-sided cardiac morphology for 69 fetuses with at least two examinations, the regression analysis of which is displayed in Table 2 . The mean ± SD gestational age at first scan was 24.3 ± 4.2 weeks and at the last scan was 32.9 ± 3.0 weeks. The median Z-scores at first echo were as follows: mitral valve diameter −2.2 (range, −8.7 to However there was no difference in the growth velocity of Z-scores for aortic valve diameter (P = 0.229) between fetuses with different circulatory outcomes ( Table 2) . Thirteen fetuses had an alteration in physiology during the second and third trimesters; two showed new left-to-right flow across the foramen ovale, one of which also had new reversal of aortic arch flow, while one fetus showed normalization of foramen flow. Six fetuses showed deterioration of mitral valve flow, three developing atresia and three developing short, monophasic mitral valve inflow, one of which also showed new Data are given as n. *Includes one case of BV-to-UV conversion. †Includes two cases of BV-to-UV conversion.
reversed flow in the transverse aortic arch. A further three fetuses showed new retrograde arch flow and one normalized during pregnancy. Although not statistically significant, 5/6 fetuses whose mitral valve became atretic or monophasic in pregnancy had UV circulation after birth (P = 0.069), while the development of new retrograde arch flow alone was equally likely to result in a BV (n = 3) as UV (n = 3) postnatal circulation (P = 1.00). Figure 2 shows that 13/40 (33%) fetuses that satisfied the criteria for emerging HLHS 6 had a BV circulation after birth, nine of which were alive at a median of 6.9 (range, 4.2-8.9) years. Table 3 shows the proportion of these 40 fetuses with emerging HLHS that would have also been considered ideal candidates for FV using the threshold score 2 . Twelve (30%) of the 40 fetuses had a threshold score of 4 or 5, thus satisfying the criteria for an FV. Five (42%) of these 12 had postnatal BV circulation without fetal intervention.
Published selection criteria
Postnatal management and survival analysis
Postnatal management was decided by the local teams and 51 neonates were assigned to a BV pathway initially, seven of which required subsequent conversion to a UV pathway, and 29 followed an initial UV pathway. There were 11 early hospital deaths (13.8% 30-day mortality) after surgery or interventional catheter; seven following Norwood Stage 1 (one after Rashkind); two after aortic valvuloplasty (one was a 31-week premature baby and one had a giant right atrium with bronchial compression after lobectomy). Another died from septicemia at 13 days old after aortic valvuloplasty followed by stenting of the isthmus and duct, and one died at 30 days old following the Ross procedure for severe aortic regurgitation and LV dysfunction. Three of these had an intact atrial septum at delivery. Of all 85 neonates considered for treatment after birth (Figure 1 ), 16 died in the first 30 days (18.8% mortality). The median follow-up of the remaining 69 was 6 years (range, 46 days to 9.6 years). Survival from birth for those undergoing an initial BV route (balloon aortic valvuloplasty or surgery) was compared with those originally designated to UV using Kaplan-Meier analysis (Figure 4) . In this analysis, the seven BV-to-UV conversions were treated as an event, removing them from the BV cohort at the time of conversion (Figure 4a ). Hazard analysis showed no significant difference in survival between the groups (73.7% vs 54.5%, P = 0.058). If these seven cases that changed circulatory designation are not included in the Kaplan-Meier analysis, those with a sustained BV circulation show a small but significant survival advantage over those with UV circulation (76.1% vs 54.5%, P = 0.041, Figure 4b ). The deaths were clustered in the first 2 years, with no further demises to almost 10 years. Table S5 lists the number and type of interventions undergone by the 80 children who had postnatal treatment. There were a total of 200 catheter and surgical procedures: the 29 neonates that followed an initial UV pathway from birth had 67 procedures, with nine dying after Norwood Stage 1 and three after the Glenn procedure (59% survival). The 44 cases with a sustained BV circulation had a total of 92 procedures and eight deaths occurred (82% survival). Seven children that required conversion from BV to UV pathway had a total of 41 procedures between them and two died (71% survival). They were converted at median age of 27 (8-286) days to a UV circulatory pathway and three had hybrid procedures that accounted for the majority of the interventions. Two infants died (at 2 months and at 1.7 years) following the hybrid pathway, one after 12 procedures, and the remaining five were alive at almost 10 years, with one child having had 10 procedures. The first procedure among the 51 neonates that followed an initial BV pathway was balloon aortic valvuloplasty in 48 and surgical valvotomy in three. Repeat balloon valvuloplasty was required in two cases, and was associated with aortic arch repair in two and arch stenting in one. Nine had a surgical valvotomy, three as their initial procedure. Seven had mitral valve surgery (included under 'complex' and Ross in Figure 1 ), one had two surgeries for mitral valve perforation, three had additional Ross-Konno procedures and one a Ross. Another neonate had six procedures including arch stenting and dilation and another with Shone complex had four surgeries requiring coarctation repair and resection of subaortic membranes as well as supramitral valve surgery. Seven cases overall had Ross procedures, one with subaortic shelf resection and another had homograft replacement, and five underwent the Ross-Konno procedure. Two neonates were reported to have pulmonary hypertension: one with a giant left atrium compressing the bronchi died in the neonatal period after lobectomy and the other was alive at 7.5 years, not requiring medical or long-term oxygen therapy. Function is reported to be good in the surviving cohort with most in New York Heart Association (NYHA) Functional Classification 1.
DISCUSSION
Our study presents the natural history outcomes of 107 fetuses with aortic stenosis documented in the period 2005-2012. This is a large natural history series, particularly as fewer than 10% of neonates with critical aortic stenosis are reported to have had a prenatal diagnosis 1 . The strength of this cohort is that it documents outcomes of fetuses with serial fetal morphology and physiology, followed-up to over 9 years (median, 6 years), and thus provides health professionals and parents with information on both the spectrum of the disease and the prognosis in relation to circulatory outcomes.
When we applied the threshold score 2 to the 40 fetuses characterized as having emerging HLHS, 12 scored ≥ 4 and could be considered as ideal FV candidates, yet a BV outcome was achieved in five of them (42%) without fetal therapy. Moreover 29% (8/28) of the remaining fetuses that would not have been chosen for fetal therapy because of a low threshold score also had a BV outcome. We cannot know if FV would have improved outcome further in this cohort, but the proportion of BV outcomes in those considered to have emerging HLHS 6 is at least equal to that achieved following FV 2 -4 . We believe our data imply that the threshold score 2 may not be specific or sensitive enough in its selection of cases for valvuloplasty when applied to different populations.
Previous natural history studies conclude that retrograde aortic arch flow is an important predictor of evolving HLHS 6, 7 . However, we observed it in one-third of our cohort satisfying the Boston 2006 criteria for emerging HLHS that had a postnatal BV circulation. Retrograde aortic arch flow is described in aortic coarctation with BV outcome 10 and in normal fetal hearts near term 11 . Therefore we interpreted this physiological parameter cautiously.
Those with a postnatal UV circulation showed a trend towards smaller aortic valve diameters at first scan than did the BV cohort, but aortic valve growth velocities were similar in both cohorts to term. In contrast, the mitral valve diameter was significantly smaller at first scan in those with postnatal UV outcomes and its growth velocity, in common with the left ventricular inlet length and width, were reduced significantly by term in fetuses with UV compared with BV outcome. Our findings are in line with the observations of left heart growth following successful FV, where no real improvement in ventricular growth during pregnancy could be observed, despite successful intervention 2, 3 . We also observed that development of mitral valve atresia or monophasic flow during pregnancy was associated with UV circulation. This is in agreement with the selection criteria for FV in Linz in which longer mitral valve inflow duration (corrected for cardiac cycle) was predictive of postnatal BV circulation 3 . Neonatal mortality in aortic stenosis remains high compared with other cardiac lesions in Europe 12 . Our natural history cohort was not super-selected as no differences in severity were demonstrated between the ongoing pregnancies and those terminated. Further demises occurred: spontaneous fetal demise of 7.5%, pre-surgical neonatal demise of 6% and a 10% neonatal post-procedural demise. Thus the 30-day survival of a newborn intending postnatal treatment was 69/85 (81%). This is higher than the rate of survival to hospital discharge of 57.5% following FV from the IFCIR multicenter registry 4 . The proportion of early survivors is influenced by disease severity, and between one-half and two-thirds of our neonates receiving postnatal therapy fulfilled the characteristics of evolving HLHS 6 . This increased their risk of dying during the study period four-fold compared with those with better anatomy and physiology at the first fetal scan.
Our natural history data show important similarities with the outcomes of the first 100 FV performed in Boston over a similar time period 13 . Both show similar survival of the BV and HLHS cohorts. Differences in survival become apparent only when cardiac deaths and conversions from UV to BV were included in the Boston analysis, whereas we demonstrated better BV survival when those requiring conversion from BV to UV circulations were not included in the analysis. However the final outcome depends not only on prenatal appearances but also on postnatal decision-making and team ethos, including the skill to maintain a BV circulation 9,13 -17 . The choice of postnatal circulatory pathway depends on neonatal appearances, functional parameters and local preferences 9 and our children with aortic stenosis required a median of three episodes of often complex surgery, in line with others, and some had multiple catheter interventions 3,13 -17 . In our cohort, worse outcomes were identified in children undergoing multiple interventional catheter procedures (Table S5) . Hybrid procedures reported in the European Congenital Heart Surgeons Association (ECHSA) database have a 38% 30-day mortality with survival to hospital discharge of only 42% 12 . This postnatal therapeutic choice may be one reason for poor survival in some registry reports 4 . One major strength of this study is the multicenter design, which allowed us to collect a relatively large number of cases. However the multicenter retrospective nature comes with several important limitations when compared with the ideal prospective large single-center study. There was a lower degree of uniformity of data collection and although guidance was provided on how to perform all morphological measurements, we were not able to standardize and assess reproducibility of measurements as is possible in a core-lab. Moreover, postnatal management decision-making and surgical performance could not be considered uniform between centers. Other limitations of this study are common to other retrospective studies with incomplete data and inability to answer some questions. For example we do not know the decision-making behind referral for prenatal valvuloplasty or for termination of pregnancy, which lie beyond the scope of this study. The cohort has a small number that were followed-up to 10 years, which reduces the power to make firm conclusions but the event rate after 18 months was low. We might anticipate more events occurring in later adolescence in both cohorts.
In conclusion, our large natural history cohort of children diagnosed with aortic stenosis prenatally and known outcomes shows that a substantial proportion of fetuses that met the criteria for emerging HLHS and were ideal candidates for FV had a sustained BV circulation without fetal intervention. This indicates that further work is needed to refine selection criteria to offer appropriate therapy to fetuses with aortic stenosis.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1
Continuous fetal variables measured at first scan for entire study population (including fetal demises) separated into termination of pregnancy (TOP) and ongoing pregnancies, whether or not there was subsequent fetal demise 
